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Abstract
 
Gender-specific changes in Quality of Life (QoL) following cardiovascular disease (CVD) were studied in 208 patients to determine whether
gender-related differences in postmorbid QoL result from differences in disease severity, premorbid QoL, or different CVD-related recovery. Pre-
morbid data were available from a community-based survey. Follow-ups were done at 6 weeks, 6 months, and 12 months after diagnosis. Results
showed that females had worse QoL at all three postmorbid assessments compared to males. However, multivariate analyses adjusting for premorbid
gender differences and disease severity showed no significant gender-related differences for physical and psychologic functioning. Therefore, gen-
der differences in QoL following CVD mainly result from premorbid differences in QoL, age, comorbidity, and disease severity at the time of diag-
nosis, and do not appear to be the consequence of gender-specific recovery. However, in clinical practice it is important to acknowledge the poorer
QoL of females following CVD. © 2002 Elsevier Science. All rights reserved.
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1. Introduction
 
Over the past decade, gender issues have received in-
creased attention in social and medical sciences. Health sur-
veys reveal that women have a higher prevalence of medical
conditions and psychosocial problems, such as depression,
compared to men [1–3]. The case of cardiovascular disease
(CVD) is a paradoxical one, as CVD is traditionally regarded
as a predominantly male disease [4], while recent studies re-
port that women’s CVD related morbidity and mortality after
CVD exceed that of men [5–7].
The majority of studies on quality of life (QoL) in patients
with CVD suggest that women do not cope as well physically
and psychosocially as men, as concluded in a large review by
Brezinka and Kittel [6]. Female patients score worse on psy-
chosomatic symptoms, depression, anxiety, and sleep distur-
bances compared to their male counterparts [8]. However, the
literature is not consistent, and it remains unclear why gender-
related differences in QoL exist among CVD patients. There
may be at least three theoretical explanations for a gender-
related difference in functioning following CVD. These expla-
nations are hypothetical and probably not mutually exclusive.
First, gender-related differences might be a consequence of a
more severe CVD pathology among women compared to men.
These physiologic differences in disease etiology and disease
severity between genders may exist, although they are at the
present time not well understood [9]. A second explanation for
women’s poorer functioning after CVD might be that older
women in particular generally have lower premorbid levels of
functioning than older men. This may, for example, be due to
higher levels of morbidity. Numerous studies indicate that in
community samples the prevalence of medical and psycho-
logic conditions is higher in women than in men [1–3]. Hence,
differences in QoL after CVD between males and females may
be ascribed to existing gender differences in QoL, health status,
and social disadvantages before the emergence of CVD [10]. A
third, related, explanation for women’s poorer functioning after
CVD might be that women have worse CVD-related recovery
than men independently of premorbid levels of functioning.
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This refers more explicitly to the process of adaptation after
CVD has emerged. Although gender differences in risk pro-
files for CVD have been reported [11–13], little is known about
gender-specific adaptation after CVD. In general, smoking, al-
cohol consumption, and overweight are the most common risk
factors for men; whereas psychologic distress, role pressure,
and less strenuous exercise are more characteristic of women
[14,15]. Therefore, health–behavioral adaptation processes
might be prominent for males, whereas psychosocial adapta-
tion processes might be more relevant among females. The ef-
fectiveness of these adaptation processes may differ, which
might result in gender-related differences in QoL after CVD.
The objective of the present study is to verify empirically
these three explanations. The Groningen Longitudinal Ag-
ing Study includes premorbid data, and is pre-eminently
suitable for studying these explanations of gender-related
differences in QoL of CVD patients. We examined gender-
specific changes in physical, psychological, and social func-
tioning (QoL) of elderly subjects in the year after diagnosis
of CVD. Moreover, we determined whether gender-related
differences in postmorbid QoL are a result of differences in
disease severity at the time of diagnosis, differences in pre-
morbid QoL, or premorbid social disadvantages, or gender
differences in CVD-related recovery. In comparison to most
other studies, our study was truly prospective including one
 
premorbid
 
 and three 
 
postmorbid
 
 assessments. The premor-
bid measurement was part of a large population based sur-
vey in 1993. This design allows an adjustment of possible
premorbid gender differences in QoL and other covariates,
which were present prior to diagnosis.
 
2. Methods
 
This study is part of the Groningen Longitudinal Aging
Study (GLAS). Detailed description of data collection is pub-
lished elsewhere [16–20]. Briefly, in 1993 a total of 5,279
community dwelling elderly people (
 
 
 
57 years) were inter-
viewed providing data on determinants of disease, functional
disability, QoL, well-being, and utilization of care.
 
2.1. New CVD patients
 
Two cardiovascular events were included as indicators of
CVD: acute myocardial infarction (AMI) and congestive
heart failure (CHF). From the baseline wave in 1993 until
January 1 1998, the 27 general practitioners participating in
the Morbidity Registration Network Groningen passed on
the names of all patients with a new postbaseline episode of
AMI or diagnosis of CHF according to the criteria of the In-
ternational Classification of Primary Care (ICPC) [21].
AMI was diagnosed if two of the following three symptoms
were present: (a) chest pain characteristic of myocardial is-
chemia and lasting more than 15 min, (b) abnormal ST-T
changes or Q waves on an electrocardiogram, or (c) eleva-
tion of blood cardiac enzymes (code K75 of the ICPC).
CHF was diagnosed if three of the following five symptoms
were present: (a) dependent oedema, (b) raised jugular venous
pressure or hepatomegaly in the absence of liver disease, (c)
signs of pulmonary congestion or pleural effusion, (d) en-
larged heart, and (e) dyspnoea in the absence of pulmonary
disease (code K77 of the ICPC).
During the enrolment period 207 patients with a new epi-
sode of AMI and 293 patients with a first diagnosis of CHF af-
ter baseline were recruited. Of these 500 persons with CVD 74
(15%) died before T1 and 49 persons were already participat-
ing in one of the other six GLAS cohort studies. Of the 377 po-
tential responders, 68 patients refused participation in the study
and 47 patients did not participate for other reasons (see for de-
tails: van Jaarsveld et al. [22]), leaving 262 persons for T1
(70%). Of these 262 patients who started the follow-up study,
229 (87%) participated in T2 and 208 (79%) also completed
T3. These 208 patients (89 AMI and 119 CHF) are the subjects
of this study. The 89 AMI patients include 30 females (34%)
and 59 males (66%). The proportion of females is higher
among CHF patients: 70 females (59%) and 49 males (41%).
The patient’s death explained 20 of the 54 cases of dropout.
Nonresponse analyses showed that at baseline (T0), partici-
pants were significantly younger and had better physical func-
tioning scores, on average, than nonparticipants. No significant
differences were found on other socio-demographic or QoL
variables at baseline.
 
2.2. Assessment points
 
All outcome variables were assessed on four occasions: at
baseline (T0: premorbid), 6 weeks (T1), 6 months (T2), and 12
months (T3) after diagnosis. The premorbid assessment took
place in 1993 for all participants, while the timing of T1, T2, and
T3 depended on the time of diagnosis and occurred between
1993 and 1998. The mean length of the time interval between the
baseline interview and the new episode was 26 months and
ranged from 1 to 58 months. All the data were collected in face-
to-face interviews by well-trained middle-aged women.
 
2.3. Outcome measures
 
QoL is conceptualized as relating to three domains of
functioning: physical, psychologic, and social.
 
Physical functioning
 
 was assessed with the Groningen
Activity Restriction Scale (GARS). GARS comprises 18 ADL
(activities of daily living) and IADL (instrumental activities of
daily living) items, each with four response categories.
Scores may range from 18 (no physical dysfunctioning) to
72 (maximum level of physical dysfunctioning). Examples
of GARS items are “Can you dress yourself without any
help from others?,” and “Can you walk up and down the
stairs?” The results of previous studies showed that GARS
meets the stochastic cumulative scalability criteria of the
Mokken Model [23,24].
Depressive symptoms and feelings of anxiety, indicators
of 
 
psychologic functioning
 
, were assessed with the Hospital
Anxiety and Depression Scale (HADS) [25,26]. The HADS
depression subscale was originally developed to reveal pos- 
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sible depressive states in a medical outpatient clinic setting.
Items referring to symptoms that may have a physical cause
(e.g., insomnia and weight loss) are not included in the
scale. Therefore, HADS is considered to have no bias to-
wards depressive symptoms resulting from concurrent gen-
eral medical conditions [26]. Examples of items are “I still
enjoy the things I used to enjoy,” “I feel cheerful,” and “I
get sudden feelings of panic.” Both subscales consist of
seven items, and the theoretical ranges vary from 0 to 21;
higher scores indicate more symptoms. HADS has been val-
idated for an older Dutch population [26].
 
Social functioning
 
 was assessed with two MOS SF-20 sub-
scales: MOS-social functioning and MOS-role functioning
[27]. The social functioning subscale measures the extent to
which health interferes with normal social activities such as
visiting friends, in a one-item question. The role functioning
subscale measures the extent to which health interferes with
usual daily activities such as housework or paid work. The
scale consists of two items: “Does your health keep you from
working at a job or doing work around the house?” and “Have
you been unable to do certain kinds or amounts of work, house-
work because of your health?” Both the social and role func-
tioning scales range from 0 to 100. Scores are reversed so that
higher scores indicate poorer functioning, corresponding with
scores on physical and psychologic functioning. The psycho-
metric properties of the Dutch version of the MOS scales were
approved in a pilot study [28].
 
2.4. Covariates
 
Disease severity was assessed according to the New York
Heart Association (NYHA) classification at T1 (just after diag-
nosis). This NYHA classification indicates the severity of car-
diac symptoms and may range from 1 (mild symptoms) to 4
(severe symptoms).
Premorbid social disadvantages include age, marital status
(living with or without a partner), educational level (low,
middle, high), and chronic morbidity before the development
of CVD (number of chronic conditions), because these were
found to be related with cardiac disease status [29]. These
characteristics are also associated with gender in our study
and may contribute to gender differences in QoL following
CVD. The way educational level and comorbidity were mea-
sured is reported elsewhere [30].
 
2.5. Analyses
 
Differences in QoL between male and female patients were
analyzed for significance using 
 
t
 
-tests on each of the four as-
sessment points. A 
 
P
 
-value 
 
 
 
.05 was considered statistically
significant. In the introduction, three possible explanations for
postmorbid gender differences in QoL were given. To test the
first explanation (i.e., a more severe CVD pathology among
women than men), gender differences in NYHA classification
were studied. The second explanation (i.e., gender-related dif-
ferences in QoL after CVD may be ascribed to existing differ-
ences in QoL and social disadvantages before the emergence of
CVD), was analyzed with Multivariate Analyses of Variance
(MANOVA) in which gender differences in QoL were adjusted
for covariates and levels of premorbid (baseline) QoL. The third
explanation (i.e., worse CVD-related recovery in females) was
analyzed by studying changes over time with paired 
 
t
 
-tests (i.e.,
mean change scores of QoL (T0–T1, T0–T2, and T0–T3) in
males vs. females). Again, MANOVA was used to test gender
differences in these change scores adjusted for covariates. Spe-
cific results on which of the covariates were significant are also
presented, including information about interpreting the effects.
 
3. Results
 
3.1. Patient characteristics
 
Table 1 shows the baseline characteristics of the 108 male
and 100 female patients. Females were on average older, less
educated, more likely to live without a partner, had more
chronic conditions at baseline, and reported more cardiac symp-
toms (i.e., NYHA class III/IV) at T1 (just after diagnosis) com-
pared to males.
All these characteristics were related to QoL in our
study, that is, higher age, living without partner, low educa-
tional level, and more comorbid conditions at baseline were
related to worse QoL at T0, T1, T2, and T3; in addition car-
diac symptoms at T1 were related to QoL at T1, T2, and T3
(data not shown). The baseline to CVD time interval was
not significantly different between females and males.
 
3.2. Gender differences in QoL before and after CVD
 
Gender differences in physical functioning are shown in
Figure 1. Because graphs for the other domains of QoL are
comparable, these are not presented. The bars indicate the
95% confidence intervals of the mean scores among males
 
Table 1
Baseline characteristics of 208 CVD patients
Males Females
 
P
 
-value of
gender 
difference
 
N
 
 (%) 108 (52%) 100 (48%)
Age, mean (SD) 70 (7.6) 74 (7.5) .001
Number of chronic
conditions at baseline
Mean (SD) 1.4 (1.3) 1.8 (1.5) .015
Range 0–5 0–7
Without partner (%) 16 60
 
 
 
.001
Educational level (%)
Low 18 50
Middle 68 55
High 14 5
 
 
 
.001
NYHA class at T1 (%)
I4 1 2 3
II 17 21
III 30 49
IV 12 7 .010
Interval T0–T1, mean (SD)
 
a
 
24.9 (14.8) 28.1 (16.1) .138
 
a
 
Interval between baseline (T0) and diagnosis of CVD (T1) in months 
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and females and show large individual differences. Results
on each domain of QoL are presented separately.
 
3.3. Physical functioning
 
In Table 2, mean scores on physical functioning are pre-
sented (high scores represent poorer functioning). It is obvious
that females, who already had worse premorbid physical func-
tioning (T0) than males, deteriorated even further after their
CVD event. At all measurement periods, females reported sig-
nificantly worse physical functioning than males (
 
P
 
 
 
 
 
 .001, see
Table 2). The premorbid level of physical functioning in fe-
males (26.6) was as high as men’s mean physical functioning at
T3 (1 year postmorbid) (26.2). The 
 
P
 
-values in the last column
of Table 2 indicate whether the gender differences remained
significant after adjusting for premorbid characteristics and
NYHA class. Clearly, the gender differences on physical func-
tioning were not significant after adjustment for these covari-
ates. Premorbid physical functioning, age, and comorbidity
were the significant premorbid covariates. In addition, NYHA
class at time of diagnosis added information to explain gender
differences at follow-up.
Table 3 shows change scores from baseline. Both males and
females showed significant increases in physical dysfunctioning.
 
On average, males deteriorated 4.4 points on the physical func-
tioning scale, while females deteriorated 6.3 during 1-year follow-
up. The crude comparison (unadjusted for covariates) of the mean
change scores revealed that changes among females were signifi-
cant larger than changes among males at T1 and T3 (
 
P
 
 
 
 
 
 .05).
After adjustment for covariates, these gender differences were no
longer significant. Age and NYHA class were the significant co-
variates. Thus, although substantial gender differences in post-
morbid physical functioning were found, indicating poorer adap-
tation by females, change scores from baseline indicated modest
gender differences in CVD-related recovery that were no longer
significant after adjustment for age and NYHA class.
 
3.4. Psychologic functioning
 
Feelings of anxiety and depressive symptoms were high
among females compared to males at all measurement periods
(Table 2). Mean premorbid levels of anxiety and depressive
symptoms among females (4.7 and 5.6, respectively) were
again as high as the mean postmorbid levels among males (4.5
and 5.1, respectively, at T3). Crude gender differences were
statistically significant for anxiety at T0, T2, and T3 (
 
P
 
 
 
 
 
 .05)
and for depressive symptoms at T2 and T3 (
 
P
 
 
 
 
 
 .05). Gender
differences on depressive symptoms at T0 and T1 were border-
Fig. 1. Change in physical functioning by gender in CVD patients.
 
Table 2
Gender differences in QoL before and after the development of CVD in 
older patients
 
Male
 
N 
 
  
 
108
 
a
 
 
Female
 
N 
 
  
 
100
 
a
 
 
Unadjusted
 
P
 
-value
Adjusted
 
P
 
-value
 
b
 
Physical functioning
Premorbid  21.8 (5.1) 26.6 (9.6)
 
 
 
.001 .126
6 weeks after CVD  25.5 (7.7) 32.1 (10.9) 
 
 
 
.001 .115
6 months after CVD  26.2 (7.5) 32.6 (11.6)
 
 
 
.001 .432
12 months after CVD  26.2 (7.5) 32.9 (11.8) 
 
 
 
.001 .251
Feelings of anxiety
Premorbid  3.0 (3.2) 4.7 (4.0) .002 .045
6 weeks after CVD  4.4 (3.8) 5.3 (3.8) .118 .273
6 months after CVD  4.1 (3.4) 5.5 (4.2) .014 .057
12 months after CVD  4.5 (3.5) 5.8 (4.8) .027 .101
Depressive symptoms
Premorbid  4.7 (3.7)  5.6 (3.9) .074  .767
6 weeks after CVD  4.6 (3.5) 5.5 (3.7) .067 .970
6 months after CVD  5.2 (3.7) 6.4 (4.1) .026 .462
12 months after CVD  5.1 (3.7) 6.5 (4.5) .011  .612
Social functioning
Premorbid  15.7 (22.3) 34.5 (30.5)
 
 
 
.001 .017
6 weeks after CVD  30.0 (26.1) 48.0 (32.5) 
 
 
 
.001 .006
6 months after CVD  26.3 (24.7) 42.5 (28.2)
 
 
 
.001 .042
12 months after CVD  26.9 (25.6) 45.5 (29.0)
 
 
 
.001 .459
Role functioning
Premorbid  27.0 (39.6) 49.5 (48.4)
 
 
 
.001 .111
6 weeks after CVD  43.6 (44.3) 64.8 (43.2) .001  .055
6 months after CVD  39.7 (45.8) 69.4 (39.1)
 
 
 
.001 .002
12 months after CVD  41.7 (44.0) 72.5 (40.1)
 
 
 
.001 .009
 
a
 
Figures represent mean (SD).
 
b
 
Scores are adjusted for age, marital status, educational level, and co-
morbidity index.
T1, T2, and T3 scores are also adjusted for NYHA classification and
premorbid level of functioning. 
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line significant (
 
P
 
 
 
 
 
 .10). T0 differences in anxiety remained
significant, even after adjustment for age, marital status, educa-
tional level, and comorbidity, while postmorbid gender differ-
ences on anxiety and depressive symptoms were no longer
significant after adjustment for all covariates. Again, premor-
bid functioning, age, and comorbidity appeared to be the sig-
nificant premorbid covariates. In addition NYHA class at T1
was significant in explaining gender differences at follow-up.
Mean changes over time are again presented in Table 3. Dif-
ferent patterns in change over time were identified for anxiety
and depressive symptoms for males and females. In males, an
immediate increase in feelings of anxiety was identified at T1
(
 
P
 
 
 
 
 
 .001). Among females, a gradual increase in feelings of
anxiety was found, which did not attain statistical significance
until T3 (see 
 
P
 
-values in Table 3 for significant changes within
males and females, respectively). Among males, no significant
change in depressive symptoms over time was observed, while
in females a significant increase in depressive symptoms was
found at T2 (6 months after diagnosis, 
 
P
 
 
 
 
 
 .05). Although mean
changes in anxiety over time were slightly larger for males and
mean changes in depressive symptoms were slightly more pro-
nounced among females, both the unadjusted and adjusted gen-
der differences reached no statistical significance. In other
words, men and women do not differ significantly on CVD-
related recovery in terms of changes in psychologic functioning.
 
3.5. Social and role functioning
 
The lower part of Table 2 shows significant gender differ-
ences in social and role functioning at both the premorbid and
postmorbid assessment periods. Females scored worse on so-
cial and role functioning than males. Again, mean premorbid
functioning among females was comparable to postmorbid
functioning among males. After adjustment for covariates,
gender differences remained significant for social functioning
at T0, T1, and T2 and for role functioning at T2 and T3 (differ-
ences at T1 remained borderline significant with 
 
P
 
 
 
 
 
 .10). Pre-
morbid functioning, age, comorbidity, and NYHA class were
the significant covariates for both social and role functioning.
In addition, marital status was a significant covariate for social
functioning and educational level for role functioning.
The change scores on social and role functioning of Table 3
indicated significant changes in functioning among both males
and females, without significant differences between males and
females. In other words, although premorbid functioning of
women is worse, both males and females deteriorated equally
with regard to absolute change scores on the scales.
 
3.6. Covariates
 
The multivariate analyses included several covariates.
Overall, age, comorbidity, NYHA class, and premorbid
QoL were significant covariates. Higher age, more comorbid
conditions, and higher NYHA class were independently re-
lated to worse QoL at T0, T1, T2, and T3. Higher scores on
premorbid QoL (indicating worse functioning) were related
to worse QoL at T1, T2, and T3. Although marital status
and educational level were significantly related to gender
and QoL, these were nonsignificant covariates in the multi-
variate analyses for physical and psychologic functioning.
Marital status (i.e., living without a partner) was indepen-
dently related to worse social functioning and low educa-
tional level to worse role functioning at follow-ups. With re-
 
Table 3 
Gender differences in changes on QoL from baseline functioning
 
Male
 
N 
 
  
 
108
 
a
 
Female
 
N 
 
  
 
100
 
a
 
Unadjusted
 
P
 
-value
Adjusted
 
P
 
-value
 
b
 
Physical functioning
T0-T1: onset effect
 
 
 
3.7 (5.5)***
 
 
 
5.5 (7.3)*** .048 .300
T0–T2: 6-month interval
 
 
 
4.4 (5.5)***
 
 
 
6.0 (7.6)*** .096 .737
T0–T3: 12-month interval
 
 
 
4.4 (5.7)***
 
 
 
6.3 (7.5)*** .048 .428
Feelings of anxiety
T0–T1: onset effect
 
 
 
1.4 (3.8)***
 
 
 
0.6 (4.2) .159 .747
T0–T2: 6-month interval
 
 
 
1.1 (3.5)***
 
 
 
0.8 (4.1) .574 .629
T0–T3: 12-month interval
 
 
 
1.5 (3.7)***
 
 
 
1.1 (4.2)** .586 .528
Depressive symptoms
T0–T1: onset effect
 
 
 
0.1 (3.6)
 
 
 
0.1 (3.5) .958 .559
T0–T2: 6-month interval
 
 
 
0.5 (4.0)
 
 
 
0.8 (3.8)* .629 .266
T0–T3: 12-month interval
 
 
 
0.4 (4.0)
 
 
 
0.9 (4.1)* .368 .254
Social functioning
T0–T1: onset effect
 
 
 
14.3 (31.3)***
 
 
 
13.5 (37.0)*** .862 .580
T0–T2: 6-month interval
 
 
 
10.6 (28.9)***
 
 
 
8.0 (35.3)* .564 .927
T0–T3: 12-month interval
 
 
 
11.2 (27.7)***
 
 
 
11.0 (29.7)*** .969 .249
Role functioning
T0–T1: onset effect
 
 
 
16.6 (45.8)***
 
 
 
15.3 (51.0)** .843 .677
T0–T2: 6-month interval
 
 
 
12.7 (50.1)*
 
 
 
19.9 (47.5)*** .302 .129
T0–T3: 12-month interval
 
 
 
14.7 (50.0)**
 
 
 
23.0 (45.5)*** .224 .333
 
a
 
Figures represent mean change scores from baseline and (SD). Positive changes indicate a worsening in functioning; negative changes indicate an im-
provement.
 
b
 
Change scores are adjusted for age, marital status, educational level, comorbidity index, NYHA classification but not for baseline levels.
Paired 
 
t
 
-Test on changes within respectively males or females: *P
 
 
 
.05, **P
 
 
 
.01, ***P
 
 .001.1110 C.H.M. van Jaarsveld et al. / Journal of Clinical Epidemiology 55 (2002) 1105–1112
gard to change scores: higher age and higher NYHA class
were related to greater deterioration in physical functioning
and larger increase in feelings of anxiety.
4. Discussion
The present study underlines the large impact of CVD on
the three domains of QoL (physical, psychologic, and social
functioning) for both males and females. One year after di-
agnosis, QoL is significantly lower than premorbid levels of
QoL. Significant gender-related differences were found for
all QoL measures, indicating worse QoL among females at
all assessment periods. These gender-related differences are
substantial, because mean premorbid QoL in females is
comparable to mean postmorbid QoL in males on all mea-
sures of QoL. The observed gender-related difference of 6.7
units on physical functioning at 1-year follow-up (see Table
2) indicates that, on average, females experience slightly
more problems in 6 of the 18 selected physical activities, or
a lot more problems in at least three activities compared to
males. These observations support the clinical relevance of
the gender-related difference in QoL.
In the Introduction, three possible explanations for the
lower QoL of females following CVD were presented. Con-
sistent with other studies, we found that females experience
more severe symptoms of CVD (i.e., higher NYHA class).
In our analyses, we adjusted for NYHA class to study
whether postmorbid gender differences in QoL are merely a
result of a more severe disease in females or whether differ-
ences in QoL are a result of other processes (i.e., explanation
1). Our results showed that higher NYHA class was inde-
pendently related to worse postmorbid QoL. Thus, the
worse postmorbid QoL of females compared to males may
indeed be due in part to gender differences in disease sever-
ity. We also examined to what extent the poorer baseline
characteristics of females (including premorbid levels of
QoL, advanced age, and concomitant disease) account for
their worse QoL following CVD (i.e., explanation 2). The
results show that, after adjusting for these covariates, the
postmorbid differences in QoL between males and females
largely disappear. Obviously, a large extent of the postmor-
bid gender differences in QoL is explained by differences in
premorbid characteristics. Premorbid level of QoL, age, and
comorbidity appeared to be the significant covariates.
Higher age and more comorbid conditions were related to
worse levels of premorbid QoL. Even after adjusting for
premorbid levels of QoL, age, and comorbidity were inde-
pendently related to postmorbid levels of QoL. The third ex-
planation for worse QoL of females following CVD suggested
that women might have a poorer CVD-related recovery. The
results using change scores did not back this.
In terms of absolute changes over time, the impact of
CVD on both genders seems similar. However, similar ab-
solute changes have to be interpreted carefully. Equal abso-
lute change scores in males and females may not stand for
similar changes in experienced disability in everyday life.
The mean physical deterioration of females from 27 to 33
on the GARS questionnaire may be of a different order than
the observed change in males from 22 to 26. Because pre-
morbid functioning was already worse among females, a
further six-point deterioration might have a disproportion-
ately larger impact on females. The effects on psychologic
functioning also indicate a somewhat different psychologic
impact of CVD on males and females. Clearly, at 6 weeks
after diagnosis (T1) levels of anxiety were increased in
males, whereas no effect was found in females. In addition,
the results indicated that CVD leads to an increase in de-
pressive symptoms, particularly among females. For females,
CVD might come even more as a surprise, because CVD is still
seen as a predominantly male disease [4]. Therefore, dealing
with the consequences of CVD may not at all fit in women’s
expectations of life, which may result in the specific in-
crease in depressive symptoms and the delayed increase in
feelings of anxiety in females.
It might be argued whether the worse scores on QoL
among females indicate a true difference in QoL or is a re-
sult of report bias. If females generally tend to overreport
problems in functioning and males tend to trivialize dys-
functioning, these might lead to biased results. Gender dif-
ferences in the sensitivity of self-report depression scales
are reported in the literature, suggesting separate cutoff
scores for males and females [31]. However, a recent study
does not support the opinion that females overreport mor-
bidity. In fact, males reported a higher proportion of their
conditions in response to a global question, and no evidence
was found that females were more likely to report trivial or
mental health conditions in response to the global question
[32]. Results from a study comparing self-reported disabil-
ity and performance measures also suggest that both males
and females report their disability accurately, and female’s
higher prevalence of reported functional problems is a re-
flection of true disability [33]. Thus, it is not likely that the
worse scores on each QoL measure among females are
caused by a report bias but rather reflect true gender differ-
ences in functioning.
This study has several limitations. First, in this study two
frequently occurring CVD (congestive heart failure and
acute myocardial infarction) are studied together. However,
the two cardiovascular events may have very different con-
sequences. Disease-specific analyses of our data (with less
power) showed however roughly the same gender differ-
ences, but are not presented here due to small sample num-
bers. Second, analyses pertained to only 208 patients out of
the 500 originally diagnosed patients, which might have led
to at least some selection bias. However, nonresponse is in-
evitable in geriatric research, especially when studying CVD.
In contrast to most clinical trials, our source population
included all incident cases of CVD in a cohort of elderly
people. Mortality contributed 25% of the nonresponse (n   74).
Nonresponse analyses revealed only minor differences be-
tween participants (n   208) and nonparticipants (n   292) in
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premorbid assessment and CVD diagnosis varied from imme-
diately after the baseline to 58 months (mean: 26.4 months;
SD: 15.4). QoL may have changed during the interval.
However, the length of the interval was similar for males
and females. In addition, the outcomes of our analyses
hardly changed when the baseline to CVD time interval was
included as covariate in the multivariate models. We, there-
fore, assume that variation in this interval did not substan-
tially affect the outcomes of the study.
One of the major advantages of the present study is the
inclusion of a premorbid measurement. These premorbid data
were collected as part of a large population-based survey
among elderly in 1993, in which the present study sample
participated. Comparison of the premorbid data revealed
important issues. When examining only postmorbid assess-
ments, one might conclude that females suffer from harmful
consequences of CVD to a higher degree than males. The
unadjusted results indeed indicate large gender differences
in QoL. However, after adjustment for age, marital status,
educational level, NYHA class, and baseline functioning,
most gender differences were no longer significant. This
suggests that it is not female gender in itself that makes pa-
tients more susceptible to the harmful consequences of
CVD, but that the less advantageous premorbid characteris-
tics make females more susceptible. On the other hand, al-
though adjusted differences were no longer statistically signifi-
cant, all gender differences indicate worse adaptation in
females. The adaptation to CVD is a complicated process and
large individual differences were observed. Also, within male
and female patients large individual differences were observed
in (changes in) QoL after CVD. The identification of parame-
ters, besides gender, that relate to these individual differences in
QoL following CVD is an important issue for further research.
In conclusion, the lower levels of QoL of females are statis-
tically explained by existing differences between males and fe-
males. Nevertheless, it is important to acknowledge the worse
QoL of females following CVD. In clinical practice, females
will have worse QoL, and even though these lower levels are
statistically explainable, females represent a vulnerable group
with more physical limitations, more distress, and more social
limitations and they may need specific attention.
Acknowledgments
This research is part of the Groningen Longitudinal Aging
Study (GLAS). GLAS is conducted by the Northern Centre for
Healthcare Research and various Departments of the University
of Groningen in The Netherlands. The primary departments in-
volved are Public Health & Health Psychology, Family Medi-
cine, Psychiatry, Sociology (ICS), and Human Movement Sci-
ences. GLAS and its substudies are financially supported by the
Dutch government (through NESTOR), the University of
Groningen, the Faculty of Medical Sciences, the Dutch Cancer
Foundation (NKB/KWF), and The Netherlands Organization
for Scientific Research (NWO). Preparation of this article was
supported by a grant from NWO, grant 904-59-104. The central
office of GLAS is located at the Northern Centre for Healthcare
Research, Groningen, The Netherlands (http://www.med.rug.nl/
nch/). Prof. D.J. van Veldhuisen is an established investigator of
the Netherlands Heart Foundation (grant D97.017).
References
[1] Waldron I. Sex differences in human mortality: the role of genetic
factors. Soc Sci Med 1983;17:321–33.
[2] Penning MJ, Strain LA. Gender differences in disability, assistance,
and subjective well-being in later life. J Gerontol Ser B-Psychol Sci
1994;49:S202–8.
[3] Beekman ATF, Copeland JR, Prince MJ. Review of community prev-
alence of depression in later life. Br J Psychiatry 1999;174:307–11.
[4] Sytkowski PA, Dagostino RB, Belanger A, Kannel WB. Sex and time
trends in cardiovascular disease incidence and mortality: the Framing-
ham Heart Study, 1950–1989. Am J Epidemiol 1996;143:338–50.
[5] Con AH, Linden W, Thompson JM, Ignaszewski A. The psychology
of men and women recovering from coronary artery bypass surgery. J
Cardiopulm Rehabil 1999;19:152–61.
[6] Brezinka V, Kittel F. Psychosocial factors of coronary heart disease
in women: a review. Soc Sci Med 1996;42:1351–65.
[7] Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and
1-year mortality in 1,524 women after myocardial infarction. Com-
parison with 4,315 men. Circulation 1991;83:484–91.
[8] Uuskula M. Psychological differences between young male and fe-
male survivors of myocardial infarction. Psychother Psychosom 1996;
65:327–30.
[9] Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol
1988;158:1553–60.
[10] Young RF, Kahana E. Gender, recovery from late life heart attack,
and medical care. Women Health 1993;20:11–31.
[11] Eriksson H, Wilhelmsen L, Caidahl K, Svardsudd K. Epidemiology
and prognosis of heart failure. Z Kardiol 1991;80:1–6.
[12] Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression
from hypertension to congestive heart failure. JAMA 1996;275:1557–62.
[13] Aronow WS, Ahn C. Incidence of heart failure in 2,737 older persons
with and without diabetes mellitus. Chest 1999;115:867–8.
[14] Verbrugge LM. The twain meet: empirical explanations of sex differ-
ences in health and mortality. J Health Soc Behav 1989;30:282–304.
[15] Greimel ER, Padilla GV, Grant MM. Gender differences in outcomes
among patients with cancer. Psychooncology 1998;7:197–206.
[16] Kempen GIJM, Jelicic M, Ormel J. Personality, chronic medical mor-
bidity, and health-related quality of life among older persons. Health
Psychol 1997;16:539–46.
[17] Kempen GIJM, Ormel J, Brilman EI, Relyveld J. Adaptive responses
among Dutch elderly: the impact of eight chronic medical conditions
on health-related quality of life. Am J Public Health 1997;87:38–44.
[18] Kempen GIJM, Miedema I, van de Bos GAM, Ormel J. Relationship
of domain-specific measures of health to perceived overall health
among older subjects. J Clin Epidemiol 1998;51:11–8.
[19] Ormel J, Kempen GIJM, Penninx BWJH, Brilman EI, Beekman
ATF, van Sonderen E. Chronic medical conditions and mental health
in old people: disability and psychosocial resources mediate specific
mental health effects. Psychol Med 1997;27:1065–77.
[20] Ormel J, Kempen GIJM, Deeg DJH, Brilman EI, van Sonderen E,
Relyveld J. Functioning, well-being, and health perception in late middle-
aged and older people: comparing the effects of depressive symptoms
and chronic medical conditions. J Am Geriatr Soc 1998;46:39–48.
[21] Lamberts H, Wood M. International classification of primary care.
Oxford: Oxford University Press; 1987.
[22] van Jaarsveld CHM, Sanderman R, Miedema I, Ranchor AV,
Kempen GIJM. Changes in health-related quality of life in older pa-
tients with acute myocardial infarction or congestive heart failure: a
prospective study. J Am Geriatr Soc 2001;49:1052–8.1112 C.H.M. van Jaarsveld et al. / Journal of Clinical Epidemiology 55 (2002) 1105–1112
[23] Kempen GIJM, Miedema I, Ormel J, Molenaar W. The assessment
of disability with the Groningen Activity Restriction Scale—concep-
tual framework and psychometric properties. Soc Sci Med 1996;43:
1601–10.
[24] Kempen GIJM, Suurmeijer TPBM. The development of a hierarchi-
cal polychotomous ADL-IADL Scale for noninstitutionalized elders.
Gerontologist 1990;30:497–502.
[25] Zigmond AS, Snaith RP. The hospital anxiety and depression scale.
Acta Psychiatr Scand 1983;67:361–70.
[26] Spinhoven P, Ormel J, Sloekers PPA, Kempen GIJM, Speckens
AEM, van Hemert AEM. A validation study of the Hospital and De-
pression Scale (HADS) in different groups of Dutch subjects. Psychol
Med 1997;27:363–70.
[27] Stewart AL, Hays RD, Ware JE. The MOS short-form general health
survey: reliability and validity in a patient population. Med Care 1988;
26:724–35.
[28] Kempen GIJM. Het meten van de gezondheidstoestand van ouderen;
een toepassing van een Nederlandse versie van de MOS-schaal. Tijd-
schr Gerontol Geriatr 1992;23:132–40.
[29] Penninx BWJH, Beekman ATF, Honig A, et al. Depression and car-
diac mortality—results from a community-based longitudinal study.
Arch Gen Psychiatry 2001;58:221–7.
[30] Kempen GI, Brilman EI, Ranchor AV, Ormel J. Morbidity and qual-
ity of life and the moderating effects of level of education in the eld-
erly. Soc Sci Med 1999;49:143–9.
[31] Allen-Burge R, Storandt M, Kinscherf DA, Rubin EH. Sex differ-
ences in the sensitivity of two self-report depression scales in older
depressed inpatients. Psychol Aging 1994;9:443–5.
[32] Macintyre S, Ford G, Hunt K. Do women “over-report” morbidity?
Men’s and women’s responses to structured prompting on a standard
question on long standing illness. Soc Sci Med 1999;48:89–98.
[33] Merrill SS, Seeman TE, Kasl SV, Berkman LF. Gender differences in
the comparison of self-reported disability and performance measures.
J Gerontol Ser A-Biol Sci Med 1997;52A:M19–26.